Inés López

966 total citations
18 papers, 664 citations indexed

About

Inés López is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Inés López has authored 18 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Inés López's work include Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Cells and Metastasis (3 papers). Inés López is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Cells and Metastasis (3 papers). Inés López collaborates with scholars based in Spain, Belgium and United States. Inés López's co-authors include Ignacio Gil‐Bazo, Christian Rolfo, Iosune Baraibar, Marta Román, Silvestre Vicent, Ernest Nadal, Marisol González-Huarriz, Eva Bandrés, Jesús García‐Foncillas and Nerea Bitarte and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Inés López

17 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inés López Spain 10 396 280 258 198 46 18 664
Huili Chu China 12 442 1.1× 276 1.0× 244 0.9× 187 0.9× 63 1.4× 15 710
Teppei Sugano Japan 15 404 1.0× 349 1.2× 211 0.8× 233 1.2× 38 0.8× 37 745
Kuan‐Li Wu Taiwan 12 302 0.8× 204 0.7× 247 1.0× 216 1.1× 36 0.8× 36 603
Muhammad Alamgeer Australia 13 294 0.7× 346 1.2× 176 0.7× 184 0.9× 47 1.0× 25 615
Ruixuan Geng China 12 234 0.6× 254 0.9× 148 0.6× 196 1.0× 54 1.2× 29 556
Yuanhe Wang China 12 374 0.9× 150 0.5× 311 1.2× 82 0.4× 34 0.7× 43 576
Marissa Shrader United States 9 380 1.0× 292 1.0× 158 0.6× 134 0.7× 62 1.3× 15 628
Kazuhiro Kitamura Japan 10 310 0.8× 176 0.6× 237 0.9× 233 1.2× 30 0.7× 13 558
Mengxi Huang China 15 428 1.1× 169 0.6× 195 0.8× 90 0.5× 66 1.4× 31 655
Maria Cardenas United States 6 266 0.7× 214 0.8× 198 0.8× 117 0.6× 48 1.0× 14 496

Countries citing papers authored by Inés López

Since Specialization
Citations

This map shows the geographic impact of Inés López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inés López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inés López more than expected).

Fields of papers citing papers by Inés López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inés López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inés López. The network helps show where Inés López may publish in the future.

Co-authorship network of co-authors of Inés López

This figure shows the co-authorship network connecting the top 25 collaborators of Inés López. A scholar is included among the top collaborators of Inés López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inés López. Inés López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Yuqiang, Danyang Wang, Yiying Wei, et al.. (2025). Celastrol loaded nanocomplex for painless tumor therapy via YAP inhibition. Scientific Reports. 15(1). 13133–13133.
2.
Xue, Yingchao, Zhaoxu Zhang, Inés López, et al.. (2025). The mechanotransducer Piezo1 coordinates metabolism and inflammation to promote skin growth. Nature Communications. 16(1). 6876–6876. 1 indexed citations
3.
Rodríguez‐Remírez, María, Inés López, Irati Macaya, et al.. (2024). Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation. Molecular Cancer. 23(1). 78–78. 7 indexed citations
4.
Rodríguez‐Remírez, María, Inés López, María Collantes, et al.. (2023). A novel [89Zr]-anti-PD-1-PET-CT to assess response to PD-1/PD-L1 blockade in lung cancer. Frontiers in Immunology. 14. 1272570–1272570. 1 indexed citations
5.
Román, Marta, Iosune Baraibar, Inés López, et al.. (2018). KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Molecular Cancer. 17(1). 33–33. 227 indexed citations
6.
7.
Castañón, Eduardo, Alex Soltermann, Inés López, et al.. (2017). The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche. Cancer Letters. 402. 43–51. 31 indexed citations
8.
Castañón, Eduardo, Christian Rolfo, D. Viñal, et al.. (2015). Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis. Journal of Translational Medicine. 13(1). 257–257. 27 indexed citations
9.
Castañón, Eduardo, Inés López, Josefa Salgado, et al.. (2014). Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed. Journal of Translational Medicine. 12(1). 98–98. 15 indexed citations
10.
Manrique, Irene, Paul Nguewa, Anne‐Marie Bleau, et al.. (2014). The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties. Cancer Letters. 356(2). 899–909. 28 indexed citations
11.
12.
Castañón, Eduardo, Joaquim Bosch‐Barrera, Inés López, et al.. (2013). Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy. Journal of Translational Medicine. 11(1). 13–13. 37 indexed citations
13.
Ponz‐Sarvisé, Mariano, Eduardo Castañón, Miriam Redrado, et al.. (2013). Differential Tumor Expression of Inhibitor of Differentiation-1 in Prostate Cancer Patients With Extreme Clinical Phenotypes and Prognostic Implications. Clinical Genitourinary Cancer. 12(2). 87–93. 9 indexed citations
14.
15.
Boni, Valentina, Inés López, Marisol González-Huarriz, et al.. (2012). Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients. British Journal of Cancer. 107(2). 287–290. 35 indexed citations
16.
Bandrés, Eva, Fernando Arias, Inés López, et al.. (2012). Association between a specific miRNA signature and pathological response to neoadjuvant chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC) patients.. Journal of Clinical Oncology. 30(15_suppl). e14057–e14057. 7 indexed citations
17.
Bitarte, Nerea, Eva Bandrés, Valentina Boni, et al.. (2011). MicroRNA-451 Is Involved in the Self-renewal, Tumorigenicity, and Chemoresistance of Colorectal Cancer Stem Cells. Stem Cells. 29(11). 1661–1671. 224 indexed citations
18.
Rioja, Jorge, Eva Bandrés, Inés López, et al.. (2010). Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma. British Journal of Urology. 107(11). 1833–1838. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huili Chu Breakdown of academic impact, for papers by Teppei Sugano Breakdown of academic impact, for papers by Kuan‐Li Wu Breakdown of academic impact, for papers by Muhammad Alamgeer Breakdown of academic impact, for papers by Ruixuan Geng Breakdown of academic impact, for papers by Yuanhe Wang Breakdown of academic impact, for papers by Marissa Shrader Breakdown of academic impact, for papers by Kazuhiro Kitamura Breakdown of academic impact, for papers by Mengxi Huang Breakdown of academic impact, for papers by Maria Cardenas
Rankless by CCL
2026